Skip to main content

Table 3 Association of the top 20 leading companies’ global innovation activities with DALYs by income level and region

From: Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study

  Correlation coefficient (r)
Global 0.243
 Income levela
  High Income 0.617**
  Upper Middle Income 0.539*
  Lower Middle Income 0.067
  Low Income −0.396
 Regionb
  European Region 0.596*
  Western Pacific Region 0.557*
  Region of the Americas 0.506*
  South-East Asia Region 0.232
  Eastern Mediterranean Region 0.161
  African Region −0.414
  1. aClassified by the World Bank
  2. bClassified by the WHO
  3. *p < 0.05
  4. **p < 0.01